nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.143	0.248	CbGbCtD
Temozolomide—CYP3A4—Triamcinolone—psoriatic arthritis	0.108	0.188	CbGbCtD
Temozolomide—CYP3A4—Betamethasone—psoriatic arthritis	0.0929	0.161	CbGbCtD
Temozolomide—CYP3A4—Prednisolone—psoriatic arthritis	0.0916	0.159	CbGbCtD
Temozolomide—CYP3A4—Prednisone—psoriatic arthritis	0.0865	0.15	CbGbCtD
Temozolomide—CYP3A4—Dexamethasone—psoriatic arthritis	0.054	0.0938	CbGbCtD
Temozolomide—Angioedema—Dexamethasone—psoriatic arthritis	0.000431	0.00102	CcSEcCtD
Temozolomide—Angioedema—Betamethasone—psoriatic arthritis	0.000431	0.00102	CcSEcCtD
Temozolomide—Stomatitis—Methotrexate—psoriatic arthritis	0.000428	0.00101	CcSEcCtD
Temozolomide—Angiopathy—Prednisone—psoriatic arthritis	0.000428	0.00101	CcSEcCtD
Temozolomide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000426	0.00101	CcSEcCtD
Temozolomide—Immune system disorder—Prednisone—psoriatic arthritis	0.000426	0.001	CcSEcCtD
Temozolomide—Malaise—Dexamethasone—psoriatic arthritis	0.000425	0.001	CcSEcCtD
Temozolomide—Malaise—Betamethasone—psoriatic arthritis	0.000425	0.001	CcSEcCtD
Temozolomide—Oedema—Triamcinolone—psoriatic arthritis	0.000424	0.001	CcSEcCtD
Temozolomide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000424	0.001	CcSEcCtD
Temozolomide—Vertigo—Dexamethasone—psoriatic arthritis	0.000423	0.000999	CcSEcCtD
Temozolomide—Vertigo—Betamethasone—psoriatic arthritis	0.000423	0.000999	CcSEcCtD
Temozolomide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000423	0.000998	CcSEcCtD
Temozolomide—Infection—Triamcinolone—psoriatic arthritis	0.000421	0.000993	CcSEcCtD
Temozolomide—Infection—Methylprednisolone—psoriatic arthritis	0.00042	0.000991	CcSEcCtD
Temozolomide—Insomnia—Prednisolone—psoriatic arthritis	0.000417	0.000983	CcSEcCtD
Temozolomide—Alopecia—Prednisone—psoriatic arthritis	0.000417	0.000983	CcSEcCtD
Temozolomide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000415	0.000979	CcSEcCtD
Temozolomide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000415	0.000978	CcSEcCtD
Temozolomide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000414	0.000976	CcSEcCtD
Temozolomide—Mental disorder—Prednisone—psoriatic arthritis	0.000413	0.000974	CcSEcCtD
Temozolomide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000411	0.000969	CcSEcCtD
Temozolomide—Malnutrition—Prednisone—psoriatic arthritis	0.00041	0.000968	CcSEcCtD
Temozolomide—Erythema—Prednisone—psoriatic arthritis	0.00041	0.000968	CcSEcCtD
Temozolomide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00041	0.000967	CcSEcCtD
Temozolomide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000409	0.000965	CcSEcCtD
Temozolomide—Convulsion—Dexamethasone—psoriatic arthritis	0.000408	0.000963	CcSEcCtD
Temozolomide—Convulsion—Betamethasone—psoriatic arthritis	0.000408	0.000963	CcSEcCtD
Temozolomide—Hypertension—Dexamethasone—psoriatic arthritis	0.000407	0.00096	CcSEcCtD
Temozolomide—Hypertension—Betamethasone—psoriatic arthritis	0.000407	0.00096	CcSEcCtD
Temozolomide—Myalgia—Dexamethasone—psoriatic arthritis	0.000401	0.000946	CcSEcCtD
Temozolomide—Myalgia—Betamethasone—psoriatic arthritis	0.000401	0.000946	CcSEcCtD
Temozolomide—Anxiety—Dexamethasone—psoriatic arthritis	0.0004	0.000943	CcSEcCtD
Temozolomide—Anxiety—Betamethasone—psoriatic arthritis	0.0004	0.000943	CcSEcCtD
Temozolomide—Discomfort—Betamethasone—psoriatic arthritis	0.000396	0.000935	CcSEcCtD
Temozolomide—Discomfort—Dexamethasone—psoriatic arthritis	0.000396	0.000935	CcSEcCtD
Temozolomide—Haemoglobin—Methotrexate—psoriatic arthritis	0.000396	0.000934	CcSEcCtD
Temozolomide—Pain—Prednisolone—psoriatic arthritis	0.000394	0.00093	CcSEcCtD
Temozolomide—Hepatitis—Methotrexate—psoriatic arthritis	0.000394	0.000929	CcSEcCtD
Temozolomide—Haemorrhage—Methotrexate—psoriatic arthritis	0.000394	0.000929	CcSEcCtD
Temozolomide—Pharyngitis—Methotrexate—psoriatic arthritis	0.000391	0.000923	CcSEcCtD
Temozolomide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000389	0.000918	CcSEcCtD
Temozolomide—Vision blurred—Prednisone—psoriatic arthritis	0.000387	0.000912	CcSEcCtD
Temozolomide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000386	0.000911	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000386	0.000911	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000385	0.000909	CcSEcCtD
Temozolomide—Oedema—Betamethasone—psoriatic arthritis	0.000385	0.000907	CcSEcCtD
Temozolomide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000385	0.000907	CcSEcCtD
Temozolomide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000385	0.000907	CcSEcCtD
Temozolomide—Oedema—Dexamethasone—psoriatic arthritis	0.000385	0.000907	CcSEcCtD
Temozolomide—Insomnia—Triamcinolone—psoriatic arthritis	0.000383	0.000904	CcSEcCtD
Temozolomide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000383	0.000902	CcSEcCtD
Temozolomide—Infection—Betamethasone—psoriatic arthritis	0.000382	0.000901	CcSEcCtD
Temozolomide—Infection—Dexamethasone—psoriatic arthritis	0.000382	0.000901	CcSEcCtD
Temozolomide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000381	0.000898	CcSEcCtD
Temozolomide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000381	0.000898	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00038	0.000896	CcSEcCtD
Temozolomide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00038	0.000896	CcSEcCtD
Temozolomide—Visual impairment—Methotrexate—psoriatic arthritis	0.00038	0.000896	CcSEcCtD
Temozolomide—Anaemia—Prednisone—psoriatic arthritis	0.000379	0.000895	CcSEcCtD
Temozolomide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000378	0.000892	CcSEcCtD
Temozolomide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000377	0.00089	CcSEcCtD
Temozolomide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000377	0.00089	CcSEcCtD
Temozolomide—Agitation—Prednisone—psoriatic arthritis	0.000377	0.00089	CcSEcCtD
Temozolomide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000377	0.000888	CcSEcCtD
Temozolomide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000377	0.000888	CcSEcCtD
Temozolomide—Angioedema—Prednisone—psoriatic arthritis	0.000375	0.000885	CcSEcCtD
Temozolomide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000373	0.00088	CcSEcCtD
Temozolomide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000373	0.000879	CcSEcCtD
Temozolomide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000372	0.000878	CcSEcCtD
Temozolomide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000372	0.000877	CcSEcCtD
Temozolomide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000372	0.000877	CcSEcCtD
Temozolomide—Malaise—Prednisone—psoriatic arthritis	0.00037	0.000873	CcSEcCtD
Temozolomide—Vertigo—Prednisone—psoriatic arthritis	0.000369	0.00087	CcSEcCtD
Temozolomide—Eye disorder—Methotrexate—psoriatic arthritis	0.000368	0.000869	CcSEcCtD
Temozolomide—Tinnitus—Methotrexate—psoriatic arthritis	0.000367	0.000867	CcSEcCtD
Temozolomide—Anorexia—Betamethasone—psoriatic arthritis	0.000367	0.000865	CcSEcCtD
Temozolomide—Anorexia—Dexamethasone—psoriatic arthritis	0.000367	0.000865	CcSEcCtD
Temozolomide—Urticaria—Prednisolone—psoriatic arthritis	0.000366	0.000864	CcSEcCtD
Temozolomide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000366	0.000863	CcSEcCtD
Temozolomide—Fatigue—Triamcinolone—psoriatic arthritis	0.000365	0.000862	CcSEcCtD
Temozolomide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000365	0.00086	CcSEcCtD
Temozolomide—Pain—Triamcinolone—psoriatic arthritis	0.000362	0.000855	CcSEcCtD
Temozolomide—Angiopathy—Methotrexate—psoriatic arthritis	0.000357	0.000843	CcSEcCtD
Temozolomide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000356	0.00084	CcSEcCtD
Temozolomide—Convulsion—Prednisone—psoriatic arthritis	0.000356	0.000839	CcSEcCtD
Temozolomide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000355	0.000838	CcSEcCtD
Temozolomide—Hypertension—Prednisone—psoriatic arthritis	0.000354	0.000836	CcSEcCtD
Temozolomide—Chills—Methotrexate—psoriatic arthritis	0.000354	0.000834	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00035	0.000827	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00035	0.000827	CcSEcCtD
Temozolomide—Arthralgia—Prednisone—psoriatic arthritis	0.000349	0.000824	CcSEcCtD
Temozolomide—Myalgia—Prednisone—psoriatic arthritis	0.000349	0.000824	CcSEcCtD
Temozolomide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000349	0.000824	CcSEcCtD
Temozolomide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000349	0.000822	CcSEcCtD
Temozolomide—Anxiety—Prednisone—psoriatic arthritis	0.000348	0.000821	CcSEcCtD
Temozolomide—Alopecia—Methotrexate—psoriatic arthritis	0.000348	0.000821	CcSEcCtD
Temozolomide—Insomnia—Dexamethasone—psoriatic arthritis	0.000348	0.000821	CcSEcCtD
Temozolomide—Insomnia—Betamethasone—psoriatic arthritis	0.000348	0.000821	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000347	0.000819	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000346	0.000816	CcSEcCtD
Temozolomide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000345	0.000815	CcSEcCtD
Temozolomide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000345	0.000815	CcSEcCtD
Temozolomide—Discomfort—Prednisone—psoriatic arthritis	0.000345	0.000814	CcSEcCtD
Temozolomide—Mental disorder—Methotrexate—psoriatic arthritis	0.000345	0.000814	CcSEcCtD
Temozolomide—Erythema—Methotrexate—psoriatic arthritis	0.000343	0.000809	CcSEcCtD
Temozolomide—Malnutrition—Methotrexate—psoriatic arthritis	0.000343	0.000809	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00034	0.000801	CcSEcCtD
Temozolomide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000339	0.000799	CcSEcCtD
Temozolomide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000339	0.000799	CcSEcCtD
Temozolomide—Urticaria—Triamcinolone—psoriatic arthritis	0.000337	0.000794	CcSEcCtD
Temozolomide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000336	0.000793	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000336	0.000792	CcSEcCtD
Temozolomide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000335	0.00079	CcSEcCtD
Temozolomide—Oedema—Prednisone—psoriatic arthritis	0.000335	0.00079	CcSEcCtD
Temozolomide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000335	0.00079	CcSEcCtD
Temozolomide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000334	0.000789	CcSEcCtD
Temozolomide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000334	0.000789	CcSEcCtD
Temozolomide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000334	0.000789	CcSEcCtD
Temozolomide—Infection—Prednisone—psoriatic arthritis	0.000333	0.000785	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000332	0.000783	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000332	0.000783	CcSEcCtD
Temozolomide—Back pain—Methotrexate—psoriatic arthritis	0.000332	0.000783	CcSEcCtD
Temozolomide—Fatigue—Dexamethasone—psoriatic arthritis	0.000332	0.000782	CcSEcCtD
Temozolomide—Fatigue—Betamethasone—psoriatic arthritis	0.000332	0.000782	CcSEcCtD
Temozolomide—Pain—Dexamethasone—psoriatic arthritis	0.000329	0.000776	CcSEcCtD
Temozolomide—Pain—Betamethasone—psoriatic arthritis	0.000329	0.000776	CcSEcCtD
Temozolomide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000328	0.000775	CcSEcCtD
Temozolomide—Skin disorder—Prednisone—psoriatic arthritis	0.000325	0.000768	CcSEcCtD
Temozolomide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000324	0.000764	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—psoriatic arthritis	0.000323	0.000763	CcSEcCtD
Temozolomide—Anorexia—Prednisone—psoriatic arthritis	0.000319	0.000753	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000318	0.000751	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—psoriatic arthritis	0.000317	0.000748	CcSEcCtD
Temozolomide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000317	0.000748	CcSEcCtD
Temozolomide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000317	0.000748	CcSEcCtD
Temozolomide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000315	0.000742	CcSEcCtD
Temozolomide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000315	0.000742	CcSEcCtD
Temozolomide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000312	0.000737	CcSEcCtD
Temozolomide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000312	0.000735	CcSEcCtD
Temozolomide—Malaise—Methotrexate—psoriatic arthritis	0.000309	0.00073	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—psoriatic arthritis	0.000308	0.000727	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—psoriatic arthritis	0.000307	0.000724	CcSEcCtD
Temozolomide—Urticaria—Betamethasone—psoriatic arthritis	0.000306	0.000721	CcSEcCtD
Temozolomide—Urticaria—Dexamethasone—psoriatic arthritis	0.000306	0.000721	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000305	0.00072	CcSEcCtD
Temozolomide—Dizziness—Prednisolone—psoriatic arthritis	0.000305	0.000719	CcSEcCtD
Temozolomide—Asthenia—Triamcinolone—psoriatic arthritis	0.000304	0.000717	CcSEcCtD
Temozolomide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000304	0.000717	CcSEcCtD
Temozolomide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000304	0.000717	CcSEcCtD
Temozolomide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000304	0.000717	CcSEcCtD
Temozolomide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000304	0.000717	CcSEcCtD
Temozolomide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000303	0.000716	CcSEcCtD
Temozolomide—Insomnia—Prednisone—psoriatic arthritis	0.000303	0.000715	CcSEcCtD
Temozolomide—Paraesthesia—Prednisone—psoriatic arthritis	0.000301	0.00071	CcSEcCtD
Temozolomide—Pruritus—Triamcinolone—psoriatic arthritis	0.0003	0.000707	CcSEcCtD
Temozolomide—Cough—Methotrexate—psoriatic arthritis	0.000299	0.000706	CcSEcCtD
Temozolomide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000299	0.000706	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—psoriatic arthritis	0.000297	0.000701	CcSEcCtD
Temozolomide—Dyspepsia—Prednisone—psoriatic arthritis	0.000295	0.000696	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—psoriatic arthritis	0.000292	0.000689	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—psoriatic arthritis	0.000292	0.000689	CcSEcCtD
Temozolomide—Decreased appetite—Prednisone—psoriatic arthritis	0.000291	0.000687	CcSEcCtD
Temozolomide—Rash—Prednisolone—psoriatic arthritis	0.000291	0.000686	CcSEcCtD
Temozolomide—Dermatitis—Prednisolone—psoriatic arthritis	0.00029	0.000685	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00029	0.000684	CcSEcCtD
Temozolomide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000289	0.000683	CcSEcCtD
Temozolomide—Fatigue—Prednisone—psoriatic arthritis	0.000289	0.000681	CcSEcCtD
Temozolomide—Headache—Prednisolone—psoriatic arthritis	0.000289	0.000681	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—psoriatic arthritis	0.000289	0.000681	CcSEcCtD
Temozolomide—Constipation—Prednisone—psoriatic arthritis	0.000286	0.000676	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—psoriatic arthritis	0.000282	0.000666	CcSEcCtD
Temozolomide—Dizziness—Triamcinolone—psoriatic arthritis	0.00028	0.000661	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00028	0.00066	CcSEcCtD
Temozolomide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00028	0.00066	CcSEcCtD
Temozolomide—Infection—Methotrexate—psoriatic arthritis	0.000278	0.000656	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000276	0.000651	CcSEcCtD
Temozolomide—Asthenia—Dexamethasone—psoriatic arthritis	0.000276	0.000651	CcSEcCtD
Temozolomide—Asthenia—Betamethasone—psoriatic arthritis	0.000276	0.000651	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000275	0.000648	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000274	0.000647	CcSEcCtD
Temozolomide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000274	0.000646	CcSEcCtD
Temozolomide—Nausea—Prednisolone—psoriatic arthritis	0.000274	0.000646	CcSEcCtD
Temozolomide—Pruritus—Betamethasone—psoriatic arthritis	0.000272	0.000642	CcSEcCtD
Temozolomide—Pruritus—Dexamethasone—psoriatic arthritis	0.000272	0.000642	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—psoriatic arthritis	0.000272	0.000641	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000271	0.000638	CcSEcCtD
Temozolomide—Vomiting—Triamcinolone—psoriatic arthritis	0.00027	0.000636	CcSEcCtD
Temozolomide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000269	0.000634	CcSEcCtD
Temozolomide—Rash—Triamcinolone—psoriatic arthritis	0.000267	0.00063	CcSEcCtD
Temozolomide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000267	0.00063	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—psoriatic arthritis	0.000267	0.000629	CcSEcCtD
Temozolomide—Rash—Methylprednisolone—psoriatic arthritis	0.000267	0.000629	CcSEcCtD
Temozolomide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000266	0.000629	CcSEcCtD
Temozolomide—Urticaria—Prednisone—psoriatic arthritis	0.000266	0.000628	CcSEcCtD
Temozolomide—Headache—Triamcinolone—psoriatic arthritis	0.000266	0.000626	CcSEcCtD
Temozolomide—Headache—Methylprednisolone—psoriatic arthritis	0.000265	0.000625	CcSEcCtD
Temozolomide—Abdominal pain—Prednisone—psoriatic arthritis	0.000265	0.000625	CcSEcCtD
Temozolomide—Body temperature increased—Prednisone—psoriatic arthritis	0.000265	0.000625	CcSEcCtD
Temozolomide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000263	0.000621	CcSEcCtD
Temozolomide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000263	0.000621	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000255	0.000602	CcSEcCtD
Temozolomide—Dizziness—Betamethasone—psoriatic arthritis	0.000254	0.0006	CcSEcCtD
Temozolomide—Dizziness—Dexamethasone—psoriatic arthritis	0.000254	0.0006	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—psoriatic arthritis	0.000253	0.000597	CcSEcCtD
Temozolomide—Nausea—Triamcinolone—psoriatic arthritis	0.000252	0.000594	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000251	0.000593	CcSEcCtD
Temozolomide—Nausea—Methylprednisolone—psoriatic arthritis	0.000251	0.000593	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—psoriatic arthritis	0.00025	0.000589	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—psoriatic arthritis	0.000249	0.000587	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000247	0.000582	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000246	0.000581	CcSEcCtD
Temozolomide—Vomiting—Dexamethasone—psoriatic arthritis	0.000245	0.000577	CcSEcCtD
Temozolomide—Vomiting—Betamethasone—psoriatic arthritis	0.000245	0.000577	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000243	0.000574	CcSEcCtD
Temozolomide—Rash—Betamethasone—psoriatic arthritis	0.000243	0.000572	CcSEcCtD
Temozolomide—Rash—Dexamethasone—psoriatic arthritis	0.000243	0.000572	CcSEcCtD
Temozolomide—Dermatitis—Betamethasone—psoriatic arthritis	0.000242	0.000572	CcSEcCtD
Temozolomide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000242	0.000572	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000242	0.00057	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—psoriatic arthritis	0.000241	0.000569	CcSEcCtD
Temozolomide—Headache—Dexamethasone—psoriatic arthritis	0.000241	0.000568	CcSEcCtD
Temozolomide—Headache—Betamethasone—psoriatic arthritis	0.000241	0.000568	CcSEcCtD
Temozolomide—Asthenia—Prednisone—psoriatic arthritis	0.00024	0.000567	CcSEcCtD
Temozolomide—Pain—Methotrexate—psoriatic arthritis	0.000239	0.000565	CcSEcCtD
Temozolomide—Pruritus—Prednisone—psoriatic arthritis	0.000237	0.000559	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000231	0.000544	CcSEcCtD
Temozolomide—Diarrhoea—Prednisone—psoriatic arthritis	0.000229	0.000541	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000229	0.00054	CcSEcCtD
Temozolomide—Nausea—Dexamethasone—psoriatic arthritis	0.000228	0.000539	CcSEcCtD
Temozolomide—Nausea—Betamethasone—psoriatic arthritis	0.000228	0.000539	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—psoriatic arthritis	0.000222	0.000525	CcSEcCtD
Temozolomide—Dizziness—Prednisone—psoriatic arthritis	0.000221	0.000523	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000221	0.000522	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000221	0.000522	CcSEcCtD
Temozolomide—Vomiting—Prednisone—psoriatic arthritis	0.000213	0.000502	CcSEcCtD
Temozolomide—Rash—Prednisone—psoriatic arthritis	0.000211	0.000498	CcSEcCtD
Temozolomide—Dermatitis—Prednisone—psoriatic arthritis	0.000211	0.000498	CcSEcCtD
Temozolomide—Headache—Prednisone—psoriatic arthritis	0.00021	0.000495	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000206	0.000487	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—psoriatic arthritis	0.000201	0.000474	CcSEcCtD
Temozolomide—Nausea—Prednisone—psoriatic arthritis	0.000199	0.000469	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—psoriatic arthritis	0.000198	0.000467	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000192	0.000452	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—psoriatic arthritis	0.000185	0.000437	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—psoriatic arthritis	0.000178	0.00042	CcSEcCtD
Temozolomide—Rash—Methotrexate—psoriatic arthritis	0.000177	0.000416	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—psoriatic arthritis	0.000176	0.000416	CcSEcCtD
Temozolomide—Headache—Methotrexate—psoriatic arthritis	0.000175	0.000414	CcSEcCtD
Temozolomide—Nausea—Methotrexate—psoriatic arthritis	0.000166	0.000392	CcSEcCtD
